Ritter Pharmaceuticals to Host Expert Call with Dr. William Chey on February 20, 2019
12 févr. 2019 08h30 HE
|
Ritter Pharmaceuticals, Inc.
Leading Gastrointestinal Disease Expert to Address Unmet Medical Need in Lactose Intolerance and the Potential of Phase 3 Drug Candidate RP-G28 LOS ANGELES, Feb. 12, 2019 (GLOBE NEWSWIRE) -- ...